Somaxon Pharmaceuticals, Inc. (SOMX) Posts Q2 EPS Loss of $0.33,
Tweet
Share
E-mailGet Alerts SOMX Hot Sheet
Price: $3.00 --0%
Financial Fact:
Research and development: 0
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Research and development: 0
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) reported Q2 EPS of ($0.33), $0.03 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $3.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
